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Deleterious Effects of Long-Term Single-Chamber Ventricular Pacing
In Patients With Sick Sinus Syndrome : The Hidden Benefits of Dual-
Chamber Pacing
AARON B. HESSELSON, BSBE, VICTOR PARSONNET, MD, FACC,
ALAN D. BERNSTEIN, ENGScD, FACC, GREGORY J. BONAVITA, MD
Newark, New Jersey
Nine hundred fifty patients who received three modes of primary
pacemaker systems (581 dual-chamber universal IDDD], 84 atrio-
ventricular-sequential ventriculaaiohibited [DVI] and 285 ven .
tricular-inhibited IVVI]) over 12 years were studio .] retrospee.
tively to determine the effect of pacing mode on pall: ut longevity
and the subsequent development of chronic .]trial gbrillotion or
flutter . A N patients were followed up continuously fir 7 s 8 years.
Patients were classified according to indication for permanent
pacing (sick sinus syndrome or other indication), age at pace-
maker implantation (<_70 or >70 years) and history of .]trial
tachyarrhythmia.
Fourteen percent of patients developed atria) fibrillation at
some lime during the study period . Of those, 4% had a DDD
pacemaker, 8% had a DVI pacemaker and 19% had a VVI
pacemaker. At 7 years, .]trial fibrillation was significantly more
ire4uent in the VVI group than in the DDD and DVI groups . In
patients with sick sinus syndrome, the Incidence rate was even
higher in the VVI group but appro:3sutcI5 the same In the DDD
and DVI groups., Patients in the WI and DVI groups who had had
With the development of new pacing modes and the prolif-
eration of dual-chamber pacing, it becomes important to
address a long-standing unanswered question: other than the
improvement in patients' general well-being, and perhaps in
some aspects of cerebral and visceral (renal) blood flow, are
there other benefits of dual-chamber pacing that are perhaps
more subtle but nonetheless important?
Numerous reports (1-23) have shown that atria) tachyar-
rhythmias are more likely to occur with ventricular pace-
makers (\'VI) than with atrial or dual-chamber pacemakers
(14°rb to 57% with VVI versus 0% to 23% with AAI or
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previous atrial lachyarrhythmia had a significantly higher inci-
dence of atrial fibrillation at 7 years than did those in the DDD
group.
During the entire period there were t30 deaths in the study
group, Including 22% of patients with a DDD pacemaker, AV. of
those wish a DVI pacemaker and 50% of those with a VVI
pacemaker . Patient survival at 7 years was lower in the W . group
than in the DDD or DVI groups . Survival also was poorer in the
WI group in comparison with the DDD group for all patients >70
years of age . Thus, death occurred more frequently with WI
pacing than with DDD pacing regardless of age at pacemaker
implantation or initial diagnosis .
These results suggest that the DDD mode is preferable to WI
pacing from the standpoint of patient longevity and the develop.
ment of .]trial fibrillation, especially in patients who undergo
permanent pacemaker implantation because of sick sinus syn-
drome and (hose >70
years of age at the time of pacemaker
implantation.
(J Am Coll Cordial 1992 ;19:1542-9)
dual-chamber modes (Table 1). • Presumably this tendency
results from stretching of the atria by a retrograde jet flowing
through intermittently incompetent atrioventricular (AV)
valves because of asynchronous atrial and ventricular con-
tractions and from the utrial contractions against closed AV
valves . The arguments that favor this hypothesis are sup.
ported by numerous demonstrations of greater release of
atrial natriuretic peptide in single-chamber pacing than in
-All pacing modes referred to in this report am designated by the
NASPE/BPEG Generic Pacemaker Code (developed jointly by members of
the North American Society of Paring and Electrophysiology and the British
and Elecsophysialogy Group and commonly krawn as the NBG Code (24):
AA1 = atriad pacing inhibited by sensed spontoneous aerial depolarvations ;
DDD = dual-chamber, aerial-synchronous, AV-sequential pacing with aerial
stimuli inhibited by sensing in either chamber and with vermicular stimuli
triggered by sensed mdai depularirations and inhibited by sensed ventricular
depoladzadons ; DDI = dual-chamber, AV-sequential pacing inhibited by
sensed depolarizatiom in either chamber ; DVI = dual-chamber, AV-
sequential pacing inhibited by sensed ventricular depolarisation
; VDD =
aldal-synchronous ventricular pacing triggered by sensed aerial depolanzx-
lions and inhibited by sense .M veninculer depolaeizations ; VVI = ventricular
pacing inhibited by sensed n nnri,atar depolarizatiom .
0735-1097N'L95.ea
'p < 0.05 . t8-y- cumuktive mortality. '5-year cumulative mortality. p 7 .05 . ¢Range does w illdude Ref 22 or 23
. AF = auial fibrillation: CHB =
&stdegoee complele hears blook ; DCP = dualehamher pacing ; NA = tel applicable: NR = not ¢ported
; SND = sinus node disorder. See text for definition
of
treeing
nodes.
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Table L
. Previous Reports Relating AtnaI Fibrillation and Ue:dh to Modc of Pacing
Acihorxirul
.no
.I
Pahen(eIan Momh, ofFollaw-Cp
AF if) G.las ;1) 215-17zr.,Res^a:
Santini ne A Icr
AAIIDDD 175'79
fD kiT 13116
SOD
VVI 175
At 44' 30 .
n anconi ct at . 121
AAInoDDD 153
44 C 14 SND
VVI 170
59 19' 31
MIarliOW 11i v'1 MI. 13)
A.AL'DDI 57;59 S1 13 1417
NA SND
VVI 8: 32 27
NA
Feuer el al . (4)
DU1) or 111)1
110 40
9 7 914D o: othr
VV:
1 :4 40 18'
35
Scaki e1 a1. (5)
AAI or DDD 34 '.0
0 D SND
WI 25 15
16'
'4
an Erde 1111 et a1 . (7)
v DDD
44 49 2 NA
SND or other
VVI
163 99
14' N.A
Sutton and Rutty (8)
AAI
410 4 NA
SND
VVI
651 _ .
NA
Rosengvist et D . (9)
AA[
99 44
7 9 SND
VVI 79
47 47'
Zanini et oI
. 1101
MI
45 4
SND
VVI
7 40 It'
Stmegl et a] . (III
AAI
110 40 6
SND
Wl
11^_ 37
19 7-
Sri.
(121
DDD 41 32 2
NA SNDcrother
VVI 703
69 32 NA
Snceck et-2 . ;'5)
DOD
NR NR 10 NA
SNDarcher
vvI 285
NR 30 NA
Shin nrg ci A. (14)
AAL/DDD
13'22 41
11918 27.23 SND or other
VV1 01 41
38 47'
L aogrhld at a1. (15)
ODD 43
61 2 NA SND or ether
W I 203
61 31 NA
Ktuakei et al . (16)
ML'AV-sequential
97'57 NR 1623 NA SNP
VVI
51 NR 57 NA
Alpert et al. (20)
DDD or DVI 49 1 to I8 yr NA 16
SND
vvI 79 110195'9
NA 27
W M. e1 A (72)
AAVDDD 101
:1152 NR NA II SND
V''l 7140 NR
NA 3'
E oieiam e1 A
. (23)
VDD 74 64 NA
20 CHB
YVI 74 64
NA 50'
Total or pang.
MIandDCP 2 .840
11to99 0 .21 t. 279
WI
5 .987 322099 14 .57 I5to47
'Only patients with sick sinus syndrome had a history ofalrial fibrillation
horror pacemaker implantation. AF = atria) fihrillation; SSS = sick sinus
syndrome . See text for definition of pacing modes .
dual-chamber pacing (16-18) . The predisposition to atrial
fibrillation has been said to be even more pronounced if atrial
tachyarrhythmia was present before the pacemaker was
implanted, -. situation most typically seen in the sick sinus
syndrome (4,7,19) .
For similar reasons, DVI pacing, a dual-chamber mode,
also may be associated with a higher incidence of atria]
arrhythmias because the absence of atria] sensing in this
mode prsdeces AV asynchrony and competition with the
native atrial rhythm whenever the spontaneous atrial rate
exceeds the lower rate limit of the pacemaker and whenever
atria[ extrasystoles occur (20).
Even more disturbing have been the reports that, in
comparison with atrial or dual-chamber modes, prolonged
VVI pacing may reduce life expectancy . The breakdown of
deaths in the reports summarized in Table I is 15% to 48% of
patients with a VVI pacemaker and 7% to 27% of those with
an AAI or dual-chamber pacemaker. The mortality figure is
lowest for patients with a DDD pacemaker, which maintains
AV synchrony more of the time . It is theorized that single-
chamber ventricular pacing, which lacks appropriate cou-
pling of ventricular stimuli to spontaneous atrial depolariza-
tion, can increase cardiac output only through increased
ventricular filling and stretching and that this process is
deleterious to ventricular function over the long term . Fur-
thermore, atrial tachyarrhythmias increase the likelihood of
thrombosis within the atrium and of serious or lethal sys-
temic embolization (25-28).
In an effort to throw further light on these issues, the
records of 950 patients who received a DDD (61%), DVI
(9%) or V VI (30%) pacemaker, all of whom were followed up
continuously for 7 to 8 years, were examined retrospectively
for evidence of the development of atria] fibrillation subse-
quent to permanent pacemaker implantation as a function of
pacing mode, age at the time of implantation and history of
atria] fibrillation before implantation .
Methods
Study patients and data acquisition . The follow-up rec-
ords of 950 patients who received a DDD, DVI or VVl
pacemaker from February 1977 through August 1989 were
OACC Vol . 19. No. 7
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studied retrospectively. The patients are characterized in
'fable 2 as to gender, age at the time of pacemaker implan-
tation, history of atria] fibrillation and sick sinus syndrome
as an indication for pacing. No patients were pacemaker
dependent . In addition to surveillance by their referring
physicians, all patients were followed up in the Pacemaker
Center at the Newark Beth Israel Medical Center and by
transtelephonic monitoring according to a standard,
Medicare-approved schedule. During follow-up, detailed ob-
servations were made of the clinical effectiveness of pacing,
stimulation and sensing thresholds were measured, pace-
maker programming interventions were documented and
limb lead electrocardiographic (ECG) rhythm strips and
12-lead ECGs were recorded. All patients included in the
study had regular sinus rhythm at the time of pacemaker
implantation . Most of the VVI units were implanted before
the general availability of dual-chamber pacemakers . The
DDD and DVI modes were not used in the presence of
unstable atrial rhythms, but not all patients with stable atrial
rhythms received a dual-chamber pacemaker because some
referring physicians and implanters preferred VVI devices
for unspecified reasons .
Analysis procedures . Patient longevity and the frequency
of development of atrial fibrillation were characterized by
using the Cox life-table method (29) . Patients were censored
for death, mode change, electronic component or lead failure
and loss to follow-up. Statistical comparisons of the actuarial
data between subsets of patients were performed with the
use of the "log-rank" method
(30) . The 950 patients were
classified into groups by pacing mode and were further
subgrouped according to indication for pacing and history of
atria] tachyarrhythmia, gender and age at the time of pace-
maker implantation. Chi-square and Student r tests were
applied when appropriate. Statistical significance was as-
sumed when the null hypothesis cotld be rejected at a 95%
confidence level (p = 0 .05)
; all comparisons reported herein
satisfied that criterion.
Results
Patient characteristics and pacing mode selection . No sig-
nificant differences existed among the patient subgroups
with respect to age or gender distribution. Indications for
pacing other than sick sinus sylrdrounc included second- and
third-degree heart block and hypersensitive carotid-sinus
syndrome. During the course of the study, pacemakers were
implanted by 40 different physicians . The reasoning behind
their selection of pacing mode was often obscure and could
not be determined by retrospective chart review . However,
the similarities in age and gender distribution and the inti-
mate follow-up of all patients by one oils (V .P.) support the
assumption that the mode selection process was related
strongly to implanter preference ; some physicians preferred
DDT) pacemakers, whereas others selected only VVI de-
vices. This assumption is further supported by the similarity
of these data to those obtained in other studies in which
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Characteristics of the Study Group
AiL Before
Age (yrl al
I.Pleelmm .
Pacing lxtianlc SOS
Implantation' Male
We-
Mode In 1`41)
(n IV1) (r, RI)
(n
[%])
range)
DDS 581(611 3081531 1041181 3411591 70 ; 15 m 97
DVI 84 [9) 58 [691 15 1181 54 [64) 69 ; 32 to 91
VVI 285 [301 193 1681 53 1191 155 [541 71 ; 24 to 98
Total 950 [1001 559 [591
172 1181 550158] 70 ; 15 to 98
Abbreviations as in Table 2 .
comorbidilies also were considered . Only a detailed pro-
spective study would put all questions to rest, but in light of
these results it is unlikely that any such study will be
undertaken . Prior atria) tachyarrhythmias were found to
have existed only in those patients with sick sinus syndrome
.
The average duration of follow-up for the DDD, DVI and
VVI groups was 30, 53 and 44 months, respectively (p < 0 .05
between all pairs of groups) .
Development of atrial fibrillation
. More than twice as
many patients with a VVI pacemaker developed atria) fibril-
lation as did those with dual-chamber pacing (Table 3) . At 7
years, atrial fibrillation had developed in more than three
times as many patients with a VVI pacemaker as in those
with a dual-chamber device .- The comparison was even
more dramatic in patients whose indication for pacing was
the sick sinus syndrome ; in this subgroup the incidence of
postimplantation atria) fibrillation was more than four times
as high in patients with a VVI pacemaker as in those with a
dual-chamber pacemaker. Figure 1 shows the incidence of
atria) fibrillation in the study group at 7 years, classified
according to indication for pacing and history of atria]
fibrillation before pacing . The rate of development of atria)
fibrillation during that period is shown in the time profiles of
Figure 2 for the study group as a whole as a function of
pacing mode . At 7 years atria) fibrillation was more common
in patients with sick sinus syndrome than in those with other
indications for pacing (9% vs. 3% with DDD pacing, 45% vs .
1t% with VVI pacing) . Patients with sick sinus syndrome
also had a higher incidence of atria] fibrillation at 7 years
when pacing was performed in the VVi u,,Ae (45%) than
when it was performed in the DDD (9%) or DVI (12%) mode.
Whether or not atrial fibrillation had been present before
pacemaker implantation, it was found significantly more
often in patients with a VVI pacemaker than in those with a
DDD or DVI unit (Table 4) . The t :-end continued at 8 years,
with atrial fibrillation found more frequently in the VVI
group: 54% in the total VVI group, 63% in those with sick
sinus syndrome, 72% in those with sick sinus syndrome and
previous atria) tachyarrhythmia and 41% in patients with
sick sinus syndrome but without previous atria) tachyar-
rhythmia.
-No patient underwent cardioversion. Infanenaion on changes in medica-
lion was not available, but most cases of atdal fibrillation were identified
during routine fallow-up procedures .
Atrial fibrillation inpatients >70 years of age. The overall
incidence of atrial fibrillation in patients >70 years old was
higher in the VVI group (21%) than in the DDD (4%) or DVI
(10%) group (Table 5). Figure 3 shows the incidence of atria)
fibrillation in the study group at 7 years, classified by
indication for pacing and age at the time of pacemaker
implantation . At 7 years, 47% of patients >70 years old who
had sick sinus syndrome and a VVI pacemaker had devel-
oped atrial fibrillation in comparison with 0% of those with a
DDD pacemaker and 10% of those with a DVI unit . Of those
with other indications for pacing, 23% of the DVI group had
developed atria] fibrillation in comparison with 4% of the
DDD group . At 8 years all of the patients >70 years old who
were treated with VVI pacing for sick sinus syndrome had
developed atria] fibrillation.
Atrial fibrlatbn i patients 170 years of age. The overall
incidence of atria) fibrillation in patients in this subgroup
who had sick sinus syndrome was 20% for those with a VVI
pacemaker in comparison with 5% of those with a DDD unit
(Table 6)
. Of those with other indications for pacing, 7% with
a VVI pacemaker developed atrial fibrillation in comparison
with 1% of those with a DDD unit and no patients with a DVI
pacemaker (p = NS) .
Patient survival. The overall mortality rate was higher in
the VVI group (50%) than in the DDD (22%) or DVI (38%)
Figure
1
. Development of atria] fibrillation in the study group 7
years after ;;acenlaker implantation as a :unction of pacing mode,
classified by indication for pacing and history of atrial tachyarrhyth-
mia
. PA
= atria) tachycardia before pacemaker implantation ; SSS =
sick sinus syndrome. See text for definition of pacing modes .
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Table 3 . Incidence of Atria) Fibrillation and Death in Subsets of the Study Group
All Patients Sss No sss
Pacing AF Died Patients AF Died Patients AF Died
Mode Patients (n [%L
In Pit m 1>) In 1%11 In 1%b In 1%11 In I%U (n I%h
DDD 581 21 141 130 [221 3081531 16 [51 641201 2731411
5121
661241
DVS 284 7 (8) 32 [381 581691
5191
191331 261311
2 [81
13l5lii
VV1 285 55 1191 142 [50] 1931641 50!211 911471
921521
5151 511551
Total 950 83191 304132] 559[59] 711131 1741311 391541] 12131 1301331
0s
	
4 s s 7 e
50.11 Altar Implentatlon
VVl 255 212 167 135 103 81 48 20
1
DVI 64 71 64 50 50 36 23 8 0
too551	410	286	213	144	
95	as	u	a
Figure 2 . Rate of development of atrial fibrillation after pacemaker
implantation for the entire study group as a function of pacing mode,
determined by actuarial methods . Ninety-five percent confidence
limits at 7
years are inserted for each curve . The numbers in the
table at the bottom indicate the number of patients remaining in the
study at each time interval . See text for definition of pacing modes .
groups (Table 3) . Survival at 7 years is shown in Figure 4 for
the entire study group, for those with sick sinus syndrome,
and fur hose with other indications for pacing, classified by
pacing mode . Actuarial survival curves for the entire study
group, for those with sick sinus syndrome and for those with
other indications for pacing are shown in Figure 5 . classified
by mode of pacing . At 7 years, survival was significantly
poorer in the VVI group (36%) than in the DDD (55%, p <
0 .001) and DVI groups (53%, p < 0 .025), and patients paced
in the VVI mode also had poorer survival than those paced
with a DDD or DVI pacemaker regardless of the indication
Figure 3. Development of atrial fibrillation in the study group 7
years utter pacemaker implantation as a function of pacing mode,
classified by indication for pacing and age at the time of pacemaker
implantation. >70 = age greater than 70 years ; <_70 = age 70
years
or less; SSS = sick sinus syndrome. See text for definition of pacing
modes.
00.01
AF = atrial fibrillation: AT = atrial lachycandia . See text for definition of
pacing modes.
for pacing . At 8 years this trend was still evident, with only
17% of the VVI patients surviving .
Survival In patients >70 years of age . At 7 years survival
of these older patients was significantly poorer tr28% vs .
56%) in the VVI group than in the DDD group regardless of
indication for pacing (Fig. 6) . At 8 years 16% of patients with
sick sinus syndrome and a VVI pacemaker survived, but
none of those with a VVI pacemaker implanted for other
indications remained alive .
Survival in patients 5070 years of age . At 7 years survival
in this subgroup was poorer (w56% vs
. w66%) with VVI
pacing than with DDD pacing regardless of indication for
pacing (Table 6, Fig . 6), although the difference in this
younger subgroup did not reach statistical significance . At 8
years survival was reduced further for patients with sick
sinus syndrome and a VVI pacemaker (30%) and for those
who received a DVI pacemaker for other indications (30%) .
Discussion
Collection and
analysis 0f data . This study was conducted
by careful review of implantation and follow-up records in
the pacemaker clinic files . Unfortunately, the precise ratio-
nale for selection of the original pacing m .Jde was not always
available, because the pacemaker implantations were per-
formed over a 12-year period by many different implanters
and the study was not prospective . Thus, the precision of the
diagnosis of sick sinus syndrome is somewhat questionable,
although the preoperative definition of AV block was more
precise . Nonetheless, the patient mix was fairly uniform and
the presence or absence of atrial tachyarrhythmias at the
time of pacemaker implantation could be ascertained from
the records with accuracy .
For similar reasons, the cause of death was known with
certainly only when the death occurred in the hospital and
was therefore reported in the clinical record . In most in-
stances the news of death reached the investigators through
a telephone call from a family member or the family physi-
cian, through a newspaper obituary notice or through con-
tact initiated by the pacemaker clinic in the event of a missed
follow-up visit
.
Incidence of atrial fibrillation after pacemaker Implanta-
tion. The results of this study support the conclusions of
other reports (1-5,0-11,14,16) in which atrial fibrillation was
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TrItle 4.
Occurrence of Atrial Fibrillation Relative to )incidence of
Prior Atrial Tachycardia in Patients With Sick Sinus Syndrome
WI (n=255)
Conlperleon j
a . ,s
DVI (n=84) i ra.r.
I
I
DDD (n=551)
Pacing AF Prior AF No Prior AF
Made Patients
It Tin t
AT
In l`Oll
AT
Is
;7d)
3a ODD
708 16151 104
7171
204 9141
I
DVI 58
5181
IS 51331 43 0101
20
VVI 193
501261
53 23(431 140 271191
r .. .. . .. . . . . . .
Total 559 711131 172 1311 351201 387 1691 36191
Abbreviations as in Table 2 .
found to develop more often in patients with sick sins
syndrome treated with pacing in the VVI mode than in tho,e
with an AAI or dual-chamber pacemaker . Patients with sick
sinus syndrome were much more likely to develop atria)
fibrillation after receiving a VVI pacemaker if atrial tachyar-
rhythmia was already present (20% vs . 9%) . Feuer et al. (4)
found prior atrial tachyarrhythmia to be the only significant
predictor of the development
of
9trlal fibrillation in patients
with sick sinus syndrome and a VVI pacemaker . In patients
with a DDD pacemaker, Gross et al. (30) found a preopera-
tive history of atria) fibrillation and sinoatrial node disease to
be more common in patients who developed atrial fibrillation
after VVI pacing than in those who did not . Rosenqvist et al .
(9) also found that aerial fibrillation occurred more often with
VVI than with AAI pacing in patients with sick sinus
syndrome and a history of atria) tachyarrhythmia. In the
present study the development of atrial fibrillation was less
common with DDD pacing Than with VVI pacing in patients
with sick sinus syndrome whether or not they had prior atrial
tachyarrhythmia (7% with DDD vs. 43% with VVI and 4%
with DDD vs . 19% with VVI, respectively).
It has been suggested that atria) fibrillation can be pre-
vented by controlling the atrial rate (3). Unfortunately, it is
not known whether the atrium was predominantly paced or
sensed in these studies, but this suggestion appears reason-
Figure 4. Patient survival 7 years Ster pacemaker implantatio, : as a
function of pacing mode, classified by indication for pacing . SSS =
sick sinus syndrome . See text for definition of pacing modes.
54
able from th,
, present daia. 3
tt (31) . in contrast, has
stated that DDTO pacing may not control the development of
atrial fibrillation in patients with frequent atrial tachyar-
rhythmia . In the present study the impact of medications and
the exact nature and frequency of atrial tachyarrbythmia
before pacemaker implantation could not be evaluated with
confidence from the clinic records; thus, there remains some
degree of uncertsinrv on this issue .
The likelihood of developing atria] fibrillation wit
:, pacing
appears to be related to age, but atria) fibrillation was less
common in patients >70years old who were treated with DDD
pacing, regardless of the indication for pacing .
Ilosscdynade considerations. Asynchronous atrial and
ventricular contractions, especially during persistent retro-
grade ventriculoatrial (VA) conduction, have been proposed
as a likely cause of the increased incidence of development
of atrial fibrillation when VVI pacing is used (3,5,12,13, 0) .
Auial contraction against closed AV valves causes atria)
enlargement and stretching that, in turn, may sere as a
substrate that incites and supports chronic atrial fibrillation
(3). Furthermore, tricuspid valve regurgitation during ven-
tricular contraction also produces atrial dilation
. This theory
seems to be supported by the results of the Framingham
study, which concluded that myocardial damage may be
Figure 5. Actuarial survival of the entire study group 7 years after
pacemaker implantation, as a fanetion of pacing made. Ninety-five
percent confidence limits at 7 years are inserted for each curve
. The
numbers m the table at the bottom indicate the number of patients
remaining in the study at each time interval. See text for definition
of pacing modes
.
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Table 5 . Incidence of Atdal Fibrillation and Death in Patients >70 Years of Age
All Patients SSS No 555
Patients AF Died Patients AF Died Patients AF Died
Mode >70 In 1%11
In 1711)
>70
In [VI) In [VII
>70
In FAD (a 1911)
DDD 311 12141 771'51
177
9151 40 [231 134 3121 371201
DVI 41 41101 181441 311 2171
121401
11
21181 61551
VVr
177 371211 991561 113 341301 671591 64
3151
321501
Tamil 579 53 [101 194 (371 320)60%) 451141 1191371 209I0%0) 8[41 751361
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Figure 6. Patient survival at 7 years as a function of pacing mode,
classified by indication for pacing and age at the time of pacemaker
implantation . SSS = sick sinus syndrome . See text for definition of
pacing modes .
necessary for the occurrence of atrial fibrillation (32) . A
correlation between cardiac pacing and atria) pressure or
stretching also has been suggested by studies (17-19) show-
ing that levels of atria) natriuretie peptide are higher with
asynchronous contractions.
Among patients with a VVI pacemaker, those without
sick sinus syndrome, although also subject to the effects of
retrograde VA conduction and atrial stretching, experienced
less frequent atria) fibrillation than did those with sick sinus
syndrome (5% vs
. 26%). It is possible that patients with sick
sinus syndrome
may be more susceptible to the effects of
retrograde VA conduction and atria) stretching . Atrial fibril-
lation is known to occur often in patients with sick sinus
syndrome (8,33,34).
Patient survival. Patient survival at 7 years was signifi-
cattIly better when DDD pacing was used than with VVI
pacing regardless of the indication for pacing
. These results
are consistent with those of other studies (2,5,9-11,22,24) of
patients with sick sinus syndrome, in which patient survival
at 6 to 7 years was better with an AAI or dual-chamber mode
than with VVI pacing. However, the survival rate at 7 years
in most subgroups in the present series appears to be lower
than that in most previous reports for a similar time interval .
The rate found in other studies (2,5,9-11,22-24) ranged from
72% to 97% with AAI and dual-chamber modes and from
34% to 78% with VVI pacing. The results of Edelstam et al.
Table 6. Incidence of Attial Fibrillation and Death in Patients N70 Years of Age
JACC Vol. 19, No. 7
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(23) in patients with complete heart block and congestive
heart failure (73% survival at 7 years with VDD pacing, 34%
with VVI pacing) were closest to those reported here .
Differences in the results may be related to the mean age at
the lime of pacemaker implantation (range 53 to 70 years)
and the prevalence of coronary heart disease or congestive
heart failure . Information concerning these potential factors
was unavailable in some studies, including the one reported
here .
In patients >70 years old, the survival rate at 7 years was
significantly better with DDD pacing than with VVI pacing
regardless of the indication for pacing. This observation is
consistent with the results of Santini (I) and others (35,36)
who suggested that the hemodynamic damage caused by
VVI pacing in sick sinus syndrome may be less easily
tolerated than that with AAI or DDD pacing in a more
elderly population. Conversely, numerous studies (5,37-49)
also have demonstrated the clinical and hemodynamic ad-
vantages for patients of any age of pacing modes that
maintain AV synchrony .
The increased risk of stroke in atria) fibrillation is well
documented (28,50)
. Unfortunately, no correlation between
atrial fibrillation and the occurrence of death resulting from
stroke could be made in this series because, in most cases,
the precise cause of death was unknown .
Conclusions, Although the mechanism by which AAI and
DDD pacing prevent the development of atria) fibrillation
remains to be explained fully, the results of this study and
others like it show that patients with sick sinus syndrome are
less likely to develop atrial fibrillation when they are treated
with pacing in modes that maintain AV synchrony . The
results also indicate that patients >70 years old who undergo
pacemaker implantation for other reasons can benefit from
DDD as opposed to VVI pacing .
Regardless of age at pacemaker implantation, patients
with sick sinus syndrome live longer when pacing is per-
formed in the DDD mode, a finding that provides a strong
argument for maintaining AV synchrony through the use of
a DDD or AAI pacemaker in any patient whose spontaneous
atria) rhythm is stable. Because roughly 77% of pacemaker
patients are potential candidates for dual-chamber or atrial
pacing (49), these results should be taken into consideration
in selecting the appropriate node of pacing for members of
this substantial group of patients
.
Abbreviations an in Table 2 .
Mode
All Patients
sss No SSS
Patients
5570
AF
(n [%1)
Died
(n 1%
Patients
90
AF
In [%1)
Died
(n 1%1)
Patients
570
AF
In I%b
Died
(n 1%)
DDD 270
9131 53 [201 131 7 [51 241181 139
2 [11 29 [211
DVI 43
3171 141331 28 31111 71251 15
0101
7 [471
VVI 108 18 [171
43 [401 s0 16 [201 241301 28 2 [71 19 1681
Total 421 30 [71
1101261 239(11%) 26 (Ill 55 [231 162 (43%) 4 [21
55 [301
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